
Rapt Therapeutics, Vale, and AltC Acquisition are the three Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—typically roughly $300 million to $2 billion, though exact ranges vary by index and provider. They often offer higher growth potential but also come with greater volatility and liquidity risk compared with mid- and large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
Rapt Therapeutics (RAPT)
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Vale (VALE)
Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally. The company operates through Iron Solutions and Energy Transition Materials segments. The Iron Solutions segment produces and extracts iron ore and pellets, manganese, and other ferrous products; and provides related logistic services.
Read Our Latest Research Report on VALE
AltC Acquisition (ALCC)
AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.
Read Our Latest Research Report on ALCC
Featured Articles
- MarketBeat’s Top Five Stocks to Own in February 2026
- Cisco Systems Below $82? Buy Now, It Won’t Last—$182 Is Coming
- Amazon Bets Big on BETA: Why Analysts See 50% Upside
- NANO Nuclear Energy: Short-Squeeze or Rapid Meltdown Ahead
- McDonald’s Serves Up Double-Sized Tailwind for Growth
- Tesla’s Rally Setup Is Here—But Valuation Makes It Fragile
